tiprankstipranks
Trending News
More News >
Hisamitsu Pharmaceutical Co (JP:4530)
OTHER OTC:4530
Japanese Market

Hisamitsu Pharmaceutical Co (4530) Income Statement

Compare
2 Followers

Hisamitsu Pharmaceutical Co Income Statement

Last quarter (Q1 2026), Hisamitsu Pharmaceutical Co's total revenue was ¥34.66B, a decrease of -3.20% from the same quarter last year. In Q1, Hisamitsu Pharmaceutical Co's net income was ¥2.56B. See Hisamitsu Pharmaceutical Co’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
¥ 156.01B¥ 141.71B¥ 128.33B¥ 120.19B¥ 114.51B
Gross Profit
¥ 91.20B¥ 78.97B¥ 72.70B¥ 70.07B¥ 69.17B
Operating Expenses
¥ 72.30B¥ 65.80B¥ 61.10B¥ 60.73B¥ 58.50B
Depreciation and Amortization
¥ 6.33B¥ 5.17B¥ 4.95B¥ 4.32B¥ 4.08B
EBITDA
¥ 35.05B¥ 24.38B¥ 21.08B¥ 17.30B¥ 16.29B
Operating Income
¥ 18.89B¥ 13.17B¥ 11.60B¥ 9.34B¥ 10.67B
Other Income/Expenses
¥ 9.79B¥ 6.02B¥ 4.51B¥ 3.62B¥ 1.52B
Pretax Income
¥ 28.69B¥ 19.19B¥ 16.11B¥ 12.96B¥ 12.20B
Net Income
¥ 21.76B¥ 13.97B¥ 11.74B¥ 9.66B¥ 9.25B
Per Share Metrics
Basic EPS
¥ 295.57¥ 181.61¥ 148.00¥ 118.92¥ 113.21
Diluted EPS
¥ 295.15¥ 181.42¥ 147.87¥ 118.84¥ 113.10
Weighted Average Shares Outstanding
73.61M 76.92M 79.34M 81.21M 81.71M
Weighted Average Shares Outstanding (Diluted)
73.72M 77.00M 79.41M 81.27M 81.79M
Currency in JPY

Hisamitsu Pharmaceutical Co Earnings and Revenue History